A carregar...
EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo
OBJECTIVES: Triple‐negative breast cancer (TNBC) is well known for its strong invasiveness, rapid recurrence and poor prognosis. Immunotherapy, including chimeric antigen receptor‐modified T (CAR‐T) cells, has emerged as a promising tool to treat TNBC. The identification of a specific target tumor a...
Na minha lista:
| Publicado no: | Clin Transl Immunology |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7196685/ https://ncbi.nlm.nih.gov/pubmed/32373345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1135 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|